AGIO Agios Pharm

USD 43.37 -2.65 ( -5.76)%
Icon

Agios Pharm (AGIO) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 43.37

-2.65 (-5.76)%

USD 3.52B

0.96M

USD 55.44(+27.84%)

USD 61.00 (+40.65%)

Icon

AGIO

Agios Pharm (USD)
COMMON STOCK | NSD
USD 43.37
-2.65 ( -5.76)%
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 3.52B

USD 61.00 (+40.65%)

USD 43.37

Agios Pharm (AGIO) Stock Forecast

Show ratings and price targets of :
USD 55.44
(+27.84%)

Based on the Agios Pharm stock forecast from 5 analysts, the average analyst target price for Agios Pharm is USD 55.44 over the next 12 months. Agios Pharm’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Agios Pharm is Slightly Bullish , which is based on 4 positive signals and 3 negative signals. At the last closing, Agios Pharm’s stock price was USD 43.37. Agios Pharm’s stock price has changed by -27.05% over the past week, -28.27% over the past month and +97.77% over the last year.

No recent analyst target price found for Agios Pharm
No recent average analyst rating found for Agios Pharm

Company Overview Agios Pharm

Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes for the treatmen...Read More

https://www.agios.com

88 Sidney Street, Cambridge, MA, United States, 02139

383

December

USD

USA

Adjusted Closing Price for Agios Pharm (AGIO)

Loading...

Unadjusted Closing Price for Agios Pharm (AGIO)

Loading...

Share Trading Volume for Agios Pharm Shares

Loading...

Compare Performance of Agios Pharm Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for AGIO

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Agios Pharm (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc -0.93 (-0.20%) USD115.98B 32.57 215.15

Frequently Asked Questions About Agios Pharm (AGIO) Stock

Based on ratings from 5 analysts Agios Pharm's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 7 buy, sell and 2 hold ratings.

Unfortunately we do not have enough data on AGIO's stock to indicate if its a good dividend stock.

Based on targets from 5 analysts, the average taret price for AGIO is USD 55.44 over the next 12 months. The maximum analyst target price is USD 75 while the minimum anlayst target price is USD 46.

AGIO stock's Price/Earning ratio is 5.29. Our analysis grades AGIO stock's Price / Earning ratio at F. This means that AGIO stock's Price/Earning ratio is above 49% of the stocks in the Biotechnology sector in the NSD exchange. Based on this AGIO may be fairly valued for its sector

The last closing price of AGIO's stock was USD 43.37.

The most recent market capitalization for AGIO is USD 3.52B.

Based on targets from 5 analysts, the average taret price for AGIO is projected at USD 55.44 over the next 12 months. This means that AGIO's stock price may go up by +27.84% over the next 12 months.

We can't find any ETFs which contains Agios Pharm's stock.

As per our most recent records Agios Pharm has 383 Employees.

Agios Pharm's registered address is 88 Sidney Street, Cambridge, MA, United States, 02139. You can get more information about it from Agios Pharm's website at https://www.agios.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Frequently Asked Questions About Agios Pharm (AGIO) Stock

Based on ratings from 5 analysts Agios Pharm's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 7 buy, sell and 2 hold ratings.

Unfortunately we do not have enough data on AGIO's stock to indicate if its a good dividend stock.

Based on targets from 5 analysts, the average taret price for AGIO is USD 55.44 over the next 12 months. The maximum analyst target price is USD 75 while the minimum anlayst target price is USD 46.

AGIO stock's Price/Earning ratio is 5.29. Our analysis grades AGIO stock's Price / Earning ratio at F. This means that AGIO stock's Price/Earning ratio is above 49% of the stocks in the Biotechnology sector in the NSD exchange. Based on this AGIO may be fairly valued for its sector

The last closing price of AGIO's stock was USD 43.37.

The most recent market capitalization for AGIO is USD 3.52B.

Based on targets from 5 analysts, the average taret price for AGIO is projected at USD 55.44 over the next 12 months. This means that AGIO's stock price may go up by +27.84% over the next 12 months.

We can't find any ETFs which contains Agios Pharm's stock.

As per our most recent records Agios Pharm has 383 Employees.

Agios Pharm's registered address is 88 Sidney Street, Cambridge, MA, United States, 02139. You can get more information about it from Agios Pharm's website at https://www.agios.com.
Loading...